Genomics Reporting Implementation Guide
2.0.0 - trial-use

This page is part of the Genetic Reporting Implementation Guide (v2.0.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Observation: OverallInterpExample2

Generated Narrative

Resource "OverallInterpExample2"

Profile: Overall Interpretation

status: final

category: Laboratory (Observation Category Codes#laboratory)

code: Discrete variation analysis overall interpretation (LOINC#51968-6)

subject: Patient/CGPatientExample01 " EVERYMAN"

value: Positive (LOINC#LA6576-8)

specimen: Specimen/GenomicSpecimenExample01

Components

-CodeValue[x]
*Conclusion Text (To Be Determined Codes#conclusion-string)Based on the genotype result, this patient is predicted to have a CYP2C19 poor metabolizer phenotype. This genotype information can be used by patients and clinicians as part of the shared decision-making process for several drugs metabolized by CYP2C19 including clopidogrel, voriconazole, amitriptyline, citalopram and escitalopram.